Boothbay Fund Management, LLC Inmune Bio, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$14.13 - $27.85 $341,352 - $672,800	-24,158 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.29 - $19.33 $73,502 - $152,938	-7,912 Reduced 24.67%	24,158 $424,000
Q1 2021 May 17, 2021	BUY	$11.61 - $26.85 $103,433 - $239,206	8,909 Added 38.47%	32,070 $381,000
Q4 2020 Feb 12, 2021	BUY	$7.51 - $17.22 $173,939 - $398,832	23,161 New	23,161 $399,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.